This might be significant from a clinical perspective: a low false negative rate reduces the risk of underestimating more aggressive tumors, facilitating a more cautious follow-up and a timely therapeutic approach.
← all excerpts
Radiomic Analysis for Ki-67 Classification in Small Bowel Neuroendocrine Tumors.
1
—
—